Renhe Pharmacy (000650.SZ) subsidiary receives registration certificate for sodium hyaluronate eye drops.

Renhe Pharmacy (000650.SZ) announced that its subsidiary Jiangxi Shining Pharmaceutical Co., Ltd. has recently received the approval and issuance of the "Drug Registration Certificate" from the National Medical Products Administration for the sodium hyaluronate eye drops. It is known that this drug is an eye drop with sodium hyaluronate as the main ingredient, indicated for dry eye syndrome to relieve symptoms. Currently, there are several sodium hyaluronate eye drops already on the market in China.